Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CCNC | P24863 | 1/20 | 0.36 |
| ▸ | CDK8 | P49336 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25656126 | 0.91 | ENPP1 (0.43) | ENPP1MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL25656125 | 0.87 | MEN1 (0.57) | MAPTMEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL23726965 | 0.86 | ENPP1 (0.61) | ENPP1MAPTSMN1; SMN2ALDH1A1NPSR1 | |
| SCHEMBL25656012 | 0.86 | ENPP1 (0.48) | ENPP1MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL25656101 | 0.80 | LRRK2 (0.53) | ENPP1MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL23727019 | 0.78 | ENPP1 (0.61) | ENPP1MAPTSMN1; SMN2ALDH1A1NPSR1 | |
| SCHEMBL25656109 | 0.77 | ENPP1 (0.64) | ENPP1 | |
| SCHEMBL23727245 | 0.76 | PDGFRB (0.57) | ENPP1MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL25656000 | 0.75 | ENPP1 (0.73) | ENPP1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL25656031 | 0.74 | ALDH1A1 (0.52) | ENPP1MAPTSMN1; SMN2ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183212-A1 | INHIBITORS OF ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) AND METHODS OF USE THEREOF | STINGRAY THERAPEUTICS INC (US) | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183212-A1 | INHIBITORS OF ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) AND METHODS OF USE THEREOF | ENPP1, ENPP3, PPA1 | ENPP1 1/4885MAPT 4512/4885SMN1; SMN2 2933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.